Intangible Assets (Tables)

12 Months Ended

Dec. 31, 2022

Goodwill And Intangible Assets Disclosure [Abstract]

Schedule of Intangible Assets

Intangible assets consisted of the following:

			December 31, 2022										December 31, 2021
(Dollars In thousands)	Estimated Remaining Useful Lives (Years)		Cost		Disposals			Accumulated Amortization			Net Carrying Amount		Cost		Additions		Accumulated Amortization			Net Carrying Amount
Inbrija (1)		11		423,000		—			(117,927	)		305,073		423,000		—		(87,164	)		335,836
Website    development costs	1-3			14,585		(3,683	)		(10,888	)		14		14,559		26		(14,441	)		144
			$	437,585	$	(3,683	)	$	(128,815	)	$	305,087	$	437,559	$	26	$	(101,605	)	$	335,980

(1)In December 2018, the Company received FDA approval for Inbrija and accordingly reclassified the indefinite lived intangible assets to definite lived intangible assets and began amortizing the assets upon launch in February 2019.

Schedule of Estimated Future Amortization Expense for Intangible Assets

Estimated future amortization expense for intangible assets subsequent to December 31, 2021 is as follows:

(In thousands)
2023	$	30,772
2024		30,768
2025		30,764
2026		30,764
2027		30,764
Thereafter		151,255
	$	305,087